US Stock MarketDetailed Quotes

Benitec Biopharma (BNTC)

Watchlist
  • 11.840
  • -0.240-1.99%
Close May 12 16:00 ET
  • 11.840
  • 0.0000.00%
Post 16:10 ET
406.76MMarket Cap-10.96P/E (TTM)

Benitec Biopharma (BNTC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
-3K
Gross profit
0
3K
Operating expense
23.80%13.38M
69.28%9.8M
85.70%41.77M
215.74%17.18M
145.85%10.19M
56.01%10.81M
-1.41%5.79M
17.40%22.49M
19.38%5.44M
-5.71%4.14M
Selling and administrative expenses
39.17%7.54M
191.61%6.43M
235.28%23.43M
562.13%13.48M
166.67%4.21M
197.15%5.42M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-General and administrative expense
39.17%7.54M
191.61%6.43M
235.28%23.43M
562.13%13.48M
166.67%4.21M
197.15%5.42M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
Research and development costs
8.34%5.83M
-6.00%3.37M
17.45%18.33M
5.21%3.7M
133.05%5.98M
5.55%5.39M
-19.06%3.59M
22.19%15.61M
10.23%3.51M
-18.98%2.57M
Other operating expenses
----
----
----
----
----
----
----
---108K
--0
---3K
Operating profit
-23.80%-13.38M
-69.28%-9.8M
-85.70%-41.77M
-209.59%-17.18M
-146.03%-10.19M
-55.98%-10.81M
1.41%-5.79M
-17.87%-22.49M
-21.93%-5.55M
4.61%-4.14M
Net non-operating interest income expense
68.89%1.39M
67.38%1.01M
263.50%3.29M
12.61%1.04M
20,675.00%823K
13,816.67%823K
10,166.67%604K
2,839.39%904K
11,600.00%920K
42.86%-4K
Non-operating interest income
----
----
----
----
----
--823K
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
-42.86%4K
Total other finance cost
-68.89%-1.39M
-67.38%-1.01M
-263.50%-3.29M
-12.61%-1.04M
-20,675.00%-823K
---823K
-10,166.67%-604K
-2,839.39%-904K
---920K
--4K
Other net income (expense)
-65.12%150K
-235.16%-173K
440.61%562K
92.39%-7K
108.21%11K
218.52%430K
272.97%128K
63.17%-165K
10.68%-92K
-173.47%-134K
Gain on sale of security
144.56%131K
-195.70%-89K
-282.05%-71K
91.94%119K
109.32%11K
-294.70%-294K
266.07%93K
109.33%39K
369.57%62K
-140.82%-118K
Special income (charges)
--0
----
--764K
--0
--0
--764K
----
--0
--0
--0
-Less:Other special charges
----
----
---764K
--0
----
---764K
----
----
----
----
Other non- operating income (expenses)
147.50%19K
-340.00%-84K
35.78%-131K
18.18%-126K
----
-150.00%-40K
294.44%35K
-580.00%-204K
-92.50%-154K
---16K
Income before tax
-23.92%-11.84M
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-40.51%-9.55M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
Income tax
Net income
-23.92%-11.84M
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-40.51%-9.55M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
Net income continuous Operations
-23.92%-11.84M
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-40.51%-9.55M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
Minority interest income
Net income attributable to the parent company
-23.92%-11.84M
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-40.51%-9.55M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
619K
0
0
Net income attributable to common stockholders
-23.92%-11.84M
-77.21%-8.97M
-69.50%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-40.51%-9.55M
23.03%-5.06M
-14.35%-22.37M
-1.27%-4.72M
2.68%-4.28M
Basic earnings per share
0.00%-0.26
-22.22%-0.22
13.93%-1.05
-281.82%-0.42
-4.35%-0.24
90.15%-0.26
94.10%-0.18
91.36%-1.22
95.85%-0.11
91.39%-0.23
Diluted earnings per share
0.00%-0.26
-22.22%-0.22
13.93%-1.05
-281.82%-0.42
-4.35%-0.24
90.15%-0.26
94.10%-0.18
91.36%-1.22
95.85%-0.11
91.39%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0-3K
Gross profit 03K
Operating expense 23.80%13.38M69.28%9.8M85.70%41.77M215.74%17.18M145.85%10.19M56.01%10.81M-1.41%5.79M17.40%22.49M19.38%5.44M-5.71%4.14M
Selling and administrative expenses 39.17%7.54M191.61%6.43M235.28%23.43M562.13%13.48M166.67%4.21M197.15%5.42M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M
-General and administrative expense 39.17%7.54M191.61%6.43M235.28%23.43M562.13%13.48M166.67%4.21M197.15%5.42M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M
Research and development costs 8.34%5.83M-6.00%3.37M17.45%18.33M5.21%3.7M133.05%5.98M5.55%5.39M-19.06%3.59M22.19%15.61M10.23%3.51M-18.98%2.57M
Other operating expenses -------------------------------108K--0---3K
Operating profit -23.80%-13.38M-69.28%-9.8M-85.70%-41.77M-209.59%-17.18M-146.03%-10.19M-55.98%-10.81M1.41%-5.79M-17.87%-22.49M-21.93%-5.55M4.61%-4.14M
Net non-operating interest income expense 68.89%1.39M67.38%1.01M263.50%3.29M12.61%1.04M20,675.00%823K13,816.67%823K10,166.67%604K2,839.39%904K11,600.00%920K42.86%-4K
Non-operating interest income ----------------------823K----------------
Non-operating interest expense -------------------------------------42.86%4K
Total other finance cost -68.89%-1.39M-67.38%-1.01M-263.50%-3.29M-12.61%-1.04M-20,675.00%-823K---823K-10,166.67%-604K-2,839.39%-904K---920K--4K
Other net income (expense) -65.12%150K-235.16%-173K440.61%562K92.39%-7K108.21%11K218.52%430K272.97%128K63.17%-165K10.68%-92K-173.47%-134K
Gain on sale of security 144.56%131K-195.70%-89K-282.05%-71K91.94%119K109.32%11K-294.70%-294K266.07%93K109.33%39K369.57%62K-140.82%-118K
Special income (charges) --0------764K--0--0--764K------0--0--0
-Less:Other special charges -----------764K--0-------764K----------------
Other non- operating income (expenses) 147.50%19K-340.00%-84K35.78%-131K18.18%-126K-----150.00%-40K294.44%35K-580.00%-204K-92.50%-154K---16K
Income before tax -23.92%-11.84M-77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-40.51%-9.55M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M
Income tax
Net income -23.92%-11.84M-77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-40.51%-9.55M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M
Net income continuous Operations -23.92%-11.84M-77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-40.51%-9.55M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M
Minority interest income
Net income attributable to the parent company -23.92%-11.84M-77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-40.51%-9.55M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M
Preferred stock dividends
Other preferred stock dividends 00000619K00
Net income attributable to common stockholders -23.92%-11.84M-77.21%-8.97M-69.50%-37.92M-242.10%-16.15M-118.60%-9.35M-40.51%-9.55M23.03%-5.06M-14.35%-22.37M-1.27%-4.72M2.68%-4.28M
Basic earnings per share 0.00%-0.26-22.22%-0.2213.93%-1.05-281.82%-0.42-4.35%-0.2490.15%-0.2694.10%-0.1891.36%-1.2295.85%-0.1191.39%-0.23
Diluted earnings per share 0.00%-0.26-22.22%-0.2213.93%-1.05-281.82%-0.42-4.35%-0.2490.15%-0.2694.10%-0.1891.36%-1.2295.85%-0.1191.39%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More